Jan 21 Forest Laboratories Inc posted a
profit in the first full quarter under new Chief Executive Brent
Saunders, helped by higher sales of its Alzheimer's disease and
Forest said it expects adjusted earnings for its fiscal year
ending March 31 in the range of $1.25 to $1.35 per share. The
company in October forecast earnings of 95 cents to $1.15 per
The company reported a net income of about $18 million, or 7
cents per share, in the third quarter ended Dec. 31, from a loss
of $153.6 million, or 58 cents per share, a year earlier.
Total revenue rose about 23 percent to $878.4 million.